Cumberland Pharmaceuticals (CPIX) Change in Cash (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Change in Cash across 17 years of filings, most recently posting -$437448.0 for Q1 2026.

• Change in Cash for Q1 2026 came in at -$437448.0, up 84.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 19.22% YoY), and the FY2025 annual result was -$6.5 million, down 1723.94% from the prior year.
• Change in Cash came in at -$437448.0 for Q1 2026 at Cumberland Pharmaceuticals, up from -$3.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.9 million in Q2 2023 to a low of -$9.8 million in Q1 2022.
• The 5-year median for Change in Cash is $128308.0 (2024), against an average of -$943151.2.
• Peak annual rise in Change in Cash reached 666.9% in 2022, while the deepest fall reached 5879.04% in 2022.
• Cumberland Pharmaceuticals' Change in Cash stood at $216432.0 in 2022, then slumped by 186.1% to -$186341.0 in 2023, then soared by 368.02% to $499430.0 in 2024, then plunged by 851.27% to -$3.8 million in 2025, then jumped by 88.34% to -$437448.0 in 2026.
• The last three Change in Cash figures came in at -$437448.0 (Q1 2026), -$3.8 million (Q4 2025), and -$890536.0 (Q3 2025), per Business Quant data.